Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis
暂无分享,去创建一个
H. Kantarjian | J. Cortes | S. Verstovsek | C. Bueso-Ramos | J. Thiele | H. Kvasnicka | William Sun | C. Bueso‐Ramos
暂无分享,去创建一个
H. Kantarjian | J. Cortes | S. Verstovsek | C. Bueso-Ramos | J. Thiele | H. Kvasnicka | William Sun | C. Bueso‐Ramos